Els Dobbels

989 citations

21 papers · 586 indexed · h-index 11

Infectious Diseases top 5%
Virology top 2%
Emergency Medicine top 5%
Epidemiology
Pediatrics, Perinatology and Child Health top 10%

Co-authors: Barbara Laughton Mark F. Cotton Avy Violari Shabir A. Madhi Diana M. Gibb Anita Janse van Rensburg Patrick Jean‐Philippe Abdel G. Babiker
Topics: HIV Research and Treatment (17 papers)HIV/AIDS Research and Interventions (15 papers)HIV-related health complications and treatments (7 papers)
Cited by: Virology Infectious Diseases Emergency Medicine
Journals: The Lancet AIDS Vaccine
Partner nations: South Africa United States United Kingdom

In The Last Decade

Els Dobbels

21 papers receiving 576 citations

Peers

Countries citing papers authored by Els Dobbels

Since Specialization

Citations

This map shows the geographic impact of Els Dobbels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Dobbels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Dobbels more than expected).

Fields of papers citing papers by Els Dobbels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els Dobbels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Dobbels. The network helps show where Els Dobbels may publish in the future.

Co-authorship network of co-authors of Els Dobbels

This figure shows the co-authorship network connecting the top 25 collaborators of Els Dobbels. A scholar is included among the top collaborators of Els Dobbels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els Dobbels. Els Dobbels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls 2023 ·BMC Neuroscience ·(unknown),M. Holmes,Mark F. Cotton,Els Dobbels,Francesca Little,Barbara Laughton,André van der Kouwe,Frances Robertson,Ernesta M. Meintjes	2
2	Cortical structural changes related to early antiretroviral therapy (ART) interruption in perinatally HIV-infected children at 5 years of age 2021 ·IBRO Neuroscience Reports ·(unknown),M. Holmes,Mark F. Cotton,Els Dobbels,Francesca Little,Barbara Laughton,André van der Kouwe,Ernesta M. Meintjes,Frances Robertson	5
3	Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of age 2021 ·AIDS ·(unknown),Barbara Laughton,Anita Janse van Rensburg,Peter Zuidewind,Els Dobbels,Shaun Barnabas,(unknown),Mark F. Cotton,Gert U. van Zyl	6
4	Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy 2020 ·Developmental Medicine & Child Neurology ·Steve Innes,Barbara Laughton,Ronald van Toorn,Kennedy Otwombe,Afaaf Liberty,Els Dobbels,Avy Violari,Mariana Kruger,Mark F. Cotton	7
5	MRS suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infection 2020 ·NeuroImage Clinical ·(unknown),M. Holmes,Francesca Little,Els Dobbels,Mark F. Cotton,Barbara Laughton,André van der Kouwe,Ernesta M. Meintjes,Frances Robertson	16
6	Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life 2019 ·Southern African Journal of HIV Medicine ·Barbara Laughton,(unknown),Els Dobbels,Michael J. Boivin,Anita Janse van Rensburg,Richard H. Glashoff,Gert U. van Zyl,Mariana Kruger,Mark F. Cotton	7
7	Perinatal HIV Infection or Exposure Is Associated With Low N-Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years 2018 ·Frontiers in Human Neuroscience ·Frances Robertson,M. Holmes,Mark F. Cotton,Els Dobbels,Francesca Little,Barbara Laughton,André van der Kouwe,Ernesta M. Meintjes	18
8	Functional Connectivity Alterations between Networks and Associations with Infant Immune Health within Networks in HIV Infected Children on Early Treatment: A Study at 7 Years 2018 ·Frontiers in Human Neuroscience ·(unknown),Paul A. Taylor,M. Holmes,Suril Gohel,Mark F. Cotton,Els Dobbels,Barbara Laughton,Francesca Little,André van der Kouwe,Bharat B. Biswal,Ernesta M. Meintjes	10
9	Altered brain morphometry in 7-year old HIV-infected children on early ART 2017 ·Metabolic Brain Disease ·(unknown),Frances Robertson,M. Holmes,Mark F. Cotton,Els Dobbels,Francesca Little,Barbara Laughton,André van der Kouwe,Ernesta M. Meintjes	25
10	Late-Onset Hiv Encephalopathy In Children With Long-Standing Virologic Suppression Followed By Slow Spontaneous Recovery Despite no Change In Antiretroviral Therapy 2017 ·The Pediatric Infectious Disease Journal ·Steve Innes,Ronald van Toorn,Kennedy Otwombe,Els Dobbels,Gert U. van Zyl,Mark F. Cotton,Barbara Laughton	3
11	HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy 2016 ·AIDS ·(unknown),M. Holmes,Mark F. Cotton,Eva‐Maria Ratai,Francesca Little,Aaron T. Hess,Els Dobbels,André van der Kouwe,Barbara Laughton,Ernesta M. Meintjes	26
12	O50. Regional differences in absolute metabolite level couplings in a longitudinal study of children 2016 ·Physica Medica ·M. Holmes,Frances Robertson,Francesca Little,Mark F. Cotton,Els Dobbels,André van der Kouwe,Barbara Laughton,Ernesta M. Meintjes	1
13	Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown),Stéphane Hué,Avy Violari,Mark F. Cotton,Diana M. Gibb,Abdel G. Babiker,Kennedy Otwombe,Ravindre Panchia,Els Dobbels,Patrick Jean‐Philippe,James McIntyre,Deenan Pillay,Ravindra K. Gupta	8
14	White Matter Signal Abnormalities in Children With Suspected HIV-related Neurologic Disease on Early Combination Antiretroviral Therapy 2014 ·The Pediatric Infectious Disease Journal ·(unknown),Savvas Andronikou,Barbara Laughton,Martin Kidd,Els Dobbels,Steve Innes,Ronald van Toorn,Mark F. Cotton	39
15	Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial 2013 ·The Lancet ·Mark F. Cotton,Avy Violari,Kennedy Otwombe,Ravindre Panchia,Els Dobbels,Helena Rabie,(unknown),Afaaf Liberty,Erica Lazarus,Steve Innes,Anita Janse van Rensburg,(unknown),(unknown),Shabir A. Madhi,Edward Handelsman,Patrick Jean‐Philippe,James McIntyre,Diana M. Gibb,Abdel G. Babiker	181
16	Early antiretroviral therapy improves neurodevelopmental outcomes in infants 2012 ·AIDS ·Barbara Laughton,Morna Cornell,D Grové,Martin Kidd,Priscilla Springer,Els Dobbels,Anita Janse van Rensburg,Avy Violari,Abdel G. Babiker,Shabir A. Madhi,Patrick Jean‐Philippe,Diana M. Gibb,Mark F. Cotton	135
17	Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants 2012 ·Vaccine ·Shabir A. Madhi,Alane Izu,(unknown),Mark F. Cotton,Ravindre Panchia,Els Dobbels,(unknown),Nadia van Niekerk,Patrick Jean‐Philippe,Peter V. Adrian	30
18	Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the C hildren with H IV E arly Antir etroviral Therapy (CHER) Study 2011 ·BMC Research Notes ·(unknown),(unknown),(unknown),Sharon Nachman,Helena Rabie,Els Dobbels,Anita Janse van Rensburg,Morna Cornell,Avy Violari,Shabir A. Madhi,Mark F. Cotton	8
19	Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study 2011 ·BMC Pediatrics ·Heather B. Jaspan,Landon Myer,Shabir A. Madhi,Avy Violari,Diana M. Gibb,Wendy Stevens,Els Dobbels,Mark F. Cotton	2
20	Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis 2011 ·The International Journal of Tuberculosis and Lung Disease ·Helena Rabie,Avy Violari,(unknown),Shabir A. Madhi,(unknown),Steve Innes,Els Dobbels,Erica Lazarus,Ravindre Panchia,Abdel G. Babiker,Diana M. Gibb,Mark F. Cotton,(unknown)	29

About Els Dobbels

Els Dobbels is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 21 papers that have together received 586 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS Research and Interventions (15 papers) and HIV-related health complications and treatments (7 papers). The work is most often cited by research in Virology (331 citations), Infectious Diseases (395 citations) and Emergency Medicine (204 citations). Els Dobbels has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Barbara Laughton, Mark F. Cotton, Avy Violari, Shabir A. Madhi, Diana M. Gibb, Anita Janse van Rensburg, Patrick Jean‐Philippe, Abdel G. Babiker, Martin Kidd and Steve Innes. Their work appears in journals such as The Lancet, AIDS and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact